Skip to Content

Senseonics Holdings Inc SENS

Morningstar Rating
$0.42 +0.01 (3.43%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SENS is trading at a 50% discount.
Price
$0.40
Fair Value
$8.94
Uncertainty
Extreme
1-Star Price
$3.75
5-Star Price
$6.81
Economic Moat
Tsqxd
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SENS is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.40
Day Range
$0.400.43
52-Week Range
$0.401.05
Bid/Ask
$0.41 / $0.42
Market Cap
$220.82 Mil
Volume/Avg
2.2 Mil / 2.7 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
10.55
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
132

Comparables

Valuation

Metric
SENS
SIBN
300869
Price/Earnings (Normalized)
41.15
Price/Book Value
6.163.683.05
Price/Sales
10.554.237.37
Price/Cash Flow
29.80
Price/Earnings
SENS
SIBN
300869

Financial Strength

Metric
SENS
SIBN
300869
Quick Ratio
6.728.011.55
Current Ratio
7.539.013.81
Interest Coverage
−4.92−13.52
Quick Ratio
SENS
SIBN
300869

Profitability

Metric
SENS
SIBN
300869
Return on Assets (Normalized)
−46.35%−8.97%4.30%
Return on Equity (Normalized)
−179.13%−12.61%7.71%
Return on Invested Capital (Normalized)
−72.63%−11.78%4.52%
Return on Assets
SENS
SIBN
300869
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesZwjwswbgcCjdfqv$182.7 Bil
SYK
Stryker CorpZkyjptyfhNtqqn$124.6 Bil
MDT
Medtronic PLCMkfnwffmChcpspm$105.0 Bil
BSX
Boston Scientific CorpBxjvsqrjZxrvf$99.9 Bil
EW
Edwards Lifesciences CorpFyljxwjyMwpzpj$52.0 Bil
DXCM
DexCom IncMytgwbqmqZzzfh$51.8 Bil
ZBH
Zimmer Biomet Holdings IncVhfpcyzjqKmcq$24.9 Bil
ALGN
Align Technology IncJgxvskzjFpnybf$22.6 Bil
PHG
Koninklijke Philips NV ADRKphpflqkShxrpw$18.2 Bil
PODD
Insulet CorpWtyrpgnmyRzdtzfj$11.6 Bil

Sponsor Center